Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 982913, 11 pages
http://dx.doi.org/10.1155/2014/982913
Research Article

Potential Mechanisms of an Antiadenomyosis Chinese Herbal Formula Shaoyao-Gancao Decoction in Primary Cell Culture Model

1First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
3Guangdong Second Province Hospital of Traditional Chinese Medicine, Guangzhou 510095, China
4School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou 510405, China

Received 5 August 2014; Revised 11 October 2014; Accepted 15 October 2014; Published 10 November 2014

Academic Editor: Min Ye

Copyright © 2014 Yong-Ge Guan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ferenczy, “Pathophysiology of adenomyosis,” Human Reproduction Update, vol. 4, no. 4, pp. 312–322, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Azziz, “Adenomyosis: current perspectives,” Obstetrics and Gynecology Clinics of North America, vol. 16, no. 1, pp. 221–235, 1989. View at Google Scholar · View at Scopus
  3. L. Zhao, S. Zhou, L. Zou, and X. Zhao, “The expression and functionality of stromal caveolin 1 in human adenomyosis,” Human Reproduction, vol. 28, no. 5, pp. 1324–1338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Mao, Y. Wang, A. V. Carter, X. Zhen, and S.-W. Guo, “The retardation of myometrial infiltration, reduction of uterine contractility, and alleviation of generalized hyperalgesia in mice with induced adenomyosis by levo-tetrahydropalmatine (l-THP) and andrographolide,” Reproductive Sciences, vol. 18, no. 10, pp. 1025–1037, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Liu and S.-W. Guo, “A pilot study on the off-label use of valproic acid to treat adenomyosis,” Fertility and Sterility, vol. 89, no. 1, pp. 246–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Bergeron, F. Amant, and A. Ferenczy, “Pathology and physiopathology of adenomyosis,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 20, no. 4, pp. 511–521, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Grow and R. B. Filer, “Treatment of adenomyosis with long-term GnRH analogues: a case report,” Obstetrics & Gynecology, vol. 78, no. 3, part 2, pp. 538–539, 1991. View at Google Scholar · View at Scopus
  8. O. Abulafia and D. M. Sherer, “Transcatheter uterine artery embolization for the management of symptomatic uterine leiomyomas,” Obstetrical and Gynecological Survey, vol. 54, no. 12, pp. 745–753, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Goodwin, B. McLucas, M. Lee et al., “Uterine artery embolization for the treatment of uterine leiomyomata midterm results,” Journal of Vascular and Interventional Radiology, vol. 10, no. 9, pp. 1159–1165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. X. M. Wang, “The application of Shaoyao-Gancao Doction in the treatment of gynecological disorders,” Journal of Modern Medicine Health, vol. 24, no. 14, pp. 2145–2146, 2008. View at Google Scholar
  11. T. Tanaka, “A novel anti-dysmenorrhea therapy with cyclic administration of two Japanese herbal medicines,” Clinical and Experimental Obstetrics and Gynecology, vol. 30, no. 2-3, pp. 95–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Gao, “Chinese medicine therapy for uterine fibroids,” Foreign Medical Sciences (Obstet Gynecol Fascicle), vol. 30, no. 2, pp. 128–129, 2003. View at Google Scholar
  13. Y. G. Guan, Y. W. He, K. Y. Li, and Y. Song, “Effects of Shaoyao-Gancao dectionon on the expresion of Ras, Raf, and Mek-2 in human adenomyosis-derived cells,” Liaoning Journal of Traditional Chinese Medicine, vol. 41, no. 7, pp. 1530–1532, 2014. View at Google Scholar
  14. A. Imai, S. Horibe, S. Fuseya, K. Iida, H. Takagi, and T. Tamaya, “Possible evidence that the herbal medicine shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium,” Journal of Medicine, vol. 26, no. 3-4, pp. 163–174, 1995. View at Google Scholar · View at Scopus
  15. Y. Sato, T. Akao, J.-X. He et al., “Glycycoumarin from Glycyrrhizae Radix acts as a potent antispasmodic through inhibition of phosphodiesterase 3,” Journal of Ethnopharmacology, vol. 105, no. 3, pp. 409–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Y. Feng, S. Q. Yan, S. Q. Wu, and L. J. Zhang, “Experimental study on the analgesia mechanism of Paeornia and Glycyrrhiza decoction,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 25, no. 1, pp. 23–25, 2002. View at Google Scholar
  17. A. J. Zhu, B. W. Fang, X. Z. Wu, Z. S. Tian, S. D. Guo, and D. H. Li, “Study on anti-inflammation effect of shaogan decoction,” Tianjin Medical Journal, vol. 37, no. 2, pp. 120–123, 2009. View at Google Scholar
  18. T. Mori, S. Sakamoto, M. Matsuda et al., “Suppression of spontaneous development of uterine adenomyosis and mammary hyperplastic alveolar nodules by Chinese herbal medicines in mice,” The American Journal of Chinese Medicine, vol. 21, no. 3-4, pp. 263–268, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Shen, Y. Feng, D.-S. Xu, X. Lin, and L. Zhang, “Pharmacokinetic study on characteristic ingredients from Shaoyao before and after compatibility,” Chinese Pharmaceutical Journal, vol. 43, no. 23, pp. 1774–1776, 2008. View at Google Scholar · View at Scopus
  20. M. Matsuda, H. Sasabe, Y. Adachi, T. Suzuki, and T. Mori, “Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis,” The American Journal of Obstetrics and Gynecology, vol. 185, no. 6, pp. 1374–1380, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. T.-C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Ferguson, E. Kurowska, D. J. Freeman, A. F. Chambers, and D. J. Koropatnick, “A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines,” Journal of Nutrition, vol. 134, no. 6, pp. 1529–1535, 2004. View at Google Scholar · View at Scopus
  23. H. Suzuki-Kakisaka, T. Murakami, T. Hirano, Y. Terada, N. Yaegashi, and K. Okamura, “Effects of photodynamic therapy using 5-aminolevulinic acid on cultured human adenomyosis-derived cells,” Fertility and Sterility, vol. 87, no. 1, pp. 33–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-Y. Li, Z. Zhang, Z.-H. Wang, H.-W. Wang, L. Zhang, and L. Zhu, “rBTI induces apoptosis in human solid tumor cell lines by loss in mitochondrial transmembrane potential and caspase activation,” Toxicology Letters, vol. 189, no. 2, pp. 166–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. X.-Y. Song, Y.-D. Li, Y.-P. Shi, L. Jin, and J. Chen, “Quality control of traditional Chinese medicines: a review,” Chinese Journal of Natural Medicines, vol. 11, no. 6, pp. 596–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Schmahl and B. Capel, “Cell proliferation is necessary for the determination of male fate in the gonad,” Developmental Biology, vol. 258, no. 2, pp. 264–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Cooper, The Cell: A Molecular Approach, Sinauer Associates, Sunderland, Mass, USA, 2nd edition, 2000, http://www.ncbi.nlm.nih.gov/books/NBK9963/.
  28. Y.-J. Chen, H.-Y. Li, Y.-L. Chang et al., “Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors,” Fertility and Sterility, vol. 94, no. 6, pp. 1972–1979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Propst, B. J. Quade, A. R. Gargiulo, R. A. Nowak, and E. A. Stewart, “Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium,” Menopause, vol. 8, no. 5, pp. 368–371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Okada and T. W. Mak, “Pathways of apoptotic and non-apoptotic death in tumour cells,” Nature Reviews Cancer, vol. 4, no. 8, pp. 592–603, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Kokawa, T. Shikone, and R. Nakano, “Apoptosis in the human uterine endometrium during the menstrual cycle,” The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 11, pp. 4144–4147, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-H. Yang, M.-Y. Wu, C.-D. Chen, M.-J. Chen, Y.-S. Yang, and H.-N. Ho, “Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis,” Human Reproduction, vol. 22, no. 4, pp. 945–952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-H. Kim, S.-H. Jung, Y.-I. Yang et al., “Artemisia leaf extract induces apoptosis in human endometriotic cells through regulation of the p38 and NFκB pathways,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 767–775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-H. Han, M.-H. Hur, J. Buckle, J. Choi, and M. S. Lee, “Effect of aromatherapy on symptoms of dysmenorrhea in college students: a randomized placebo-controlled clinical trial,” Journal of Alternative and Complementary Medicine, vol. 12, no. 6, pp. 535–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kissler, S. Zangos, J. Kohl et al., “Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 137, no. 2, pp. 204–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Sales and H. N. Jabbour, “Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium,” Reproduction, vol. 126, no. 5, pp. 559–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Koike, H. Egawa, T. Ohtsuka, M. Yamaguchi, T. Ikenoue, and N. Mori, “Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 46, no. 2, pp. 133–137, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. K. J. Sales, V. Grant, and H. N. Jabbour, “Prostaglandin E2 and F2α activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element,” Molecular and Cellular Endocrinology, vol. 285, no. 1-2, pp. 51–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. R. Vane, Y. S. Bakhle, and R. M. Botting, “Cyclooxygenases 1 and 2,” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 97–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Lumsden, R. W. Kelly, and D. T. Baird, “Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2α,” British Journal of Obstetrics & Gynaecology, vol. 90, no. 12, pp. 1135–1140, 1983. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Shibata, T. Morimoto, A. Suzuki, H. Saito, and T. Yanaihara, “The effect of Shakuyaku-kanzo-to on prostaglandin production in human uterine myometrium,” Acta Obstetrica et Gynaecologica Japonica, vol. 48, no. 5, pp. 321–327, 1996. View at Google Scholar · View at Scopus
  43. J. Kitawaki, “Adenomyosis: the pathophysiology of an oestrogen-dependent disease,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 20, no. 4, pp. 493–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Trukhacheva, Z. Lin, S. Reierstad, Y.-H. Cheng, M. Milad, and S. E. Bulun, “Estrogen receptor (ER) β regulates ERα expression in stromal cells derived from ovarian endometriosis,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 615–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Wedrén, L. Lovmar, K. Humphreys et al., “Estrogen receptor alpha gene polymorphism and endometrial cancer risk—a case-control study,” BMC Cancer, vol. 8, article 811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Li, X. Liu, and S.-W. Guo, “Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 2, pp. 485–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Kitawaki, H. Obayashi, H. Ishihara et al., “Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata,” Human Reproduction, vol. 16, no. 1, pp. 51–55, 2001. View at Google Scholar · View at Scopus
  48. S.-W. Guo, X. Mao, Q. Ma, and X. Liu, “Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis,” Fertility and Sterility, vol. 99, no. 1, pp. 231–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Nie, X. Liu, and S.-W. Guo, “Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis,” American Journal of Obstetrics and Gynecology, vol. 202, no. 4, pp. 346.e1–346.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Zhang, S. Chen, F. Qin, X. Huang, P. Ren, and X. Gu, “Simultaneous determination of 12 chemical constituents in the traditional Chinese Medicinal Prescription Xiao-Yao-San-Jia-Wei by HPLC coupled with photodiode array detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 5, pp. 1462–1466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Q. Yin, P. Wang, A. Zhang, H. Sun, X. Wu, and X. Wang, “Ultra-performance LC-ESI/quadrupole-TOF MS for rapid analysis of chemical constituents of Shaoyao-Gancao decoction,” Journal of Separation Science, vol. 36, no. 7, pp. 1238–1246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Gan, M. Zhong, X. Huang et al., “Pharmacokinetic comparisons of albiflorin and paeoniflorin after oral administration of Shaoyao-Gancao-Tang and single herb Paeony decoction to rats,” Planta Medica, vol. 78, no. 3, pp. 237–243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Chen, J. Wang, L. Wang, L. Chen, and Q. Wu, “Absorption and interaction of the main constituents from the traditional chinese drug pair shaoyao-gancao via a caco-2 cell monolayer model,” Molecules, vol. 17, no. 12, pp. 14908–14917, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Wang, C. Xu, P. Wang et al., “Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: simultaneous determination of ten active constituents by HPLC-MS/MS,” Journal of Chromatography, vol. 932, pp. 76–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. C.-H. Xu, P. Wang, Y. Wang et al., “Pharmacokinetic comparisons of two different combinations of Shaoyao-Gancao Decoction in rats: competing mechanisms between paeoniflorin and glycyrrhetinic acid,” Journal of Ethnopharmacology, vol. 149, no. 2, pp. 443–452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Sugishita, S. Amagaya, and Y. Oghihara, “Studies on the combination of glycyrrhizae radix in shakuyakukanzo-to,” Journal of Pharmacobio-Dynamics, vol. 7, no. 7, pp. 427–435, 1984. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Yamahara, T. Yamada, H. Kimura, T. Sawada, and H. Fujimura, “Biologically active principles of crude drugs. II. Anti-allergic principles in “Shoseiryu-To” anti-inflammatory properties of paeoniflorin and its derivatives,” Journal of Pharmacobio-Dynamics, vol. 5, no. 11, pp. 921–929, 1982. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Liang, A. Zhou, M. Chen, and S. Xu, “Negatively regulatory effects of paeoniflorin on immune cells,” European Journal of Pharmacology, vol. 183, no. 3, pp. 901–902, 1990. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Ohta, J.-W. Ni, K. Matsumoto, H. Watanabe, and M. Shimizu, “Peony and its major constituent paeoniflorin, improve radial maze performance impaired by scopolamine in rats,” Pharmacology Biochemistry and Behavior, vol. 45, no. 3, pp. 719–723, 1993. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Kimura, I. Kimura, K. Takahashi et al., “Blocking effects of blended paeoniflorin or its related compounds with glycyrrhizin on neuromuscular junctions in frog and mouse,” Japanese Journal of Pharmacology, vol. 36, no. 3, pp. 275–282, 1984. View at Google Scholar · View at Scopus
  61. M. Kimura, I. Kimura, M. Muroi, T. Nakamura, and S. Shibata, “Depolarizing effects of glycyrrhizin-derivatives relating to the blend effects with paeoniflorin in mouse diaphragm muscle,” Japanese Journal of Pharmacology, vol. 41, no. 2, pp. 263–265, 1986. View at Publisher · View at Google Scholar · View at Scopus
  62. F.-L. Hsu, C.-W. Lai, and J.-T. Cheng, “Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora,” Planta Medica, vol. 63, no. 4, pp. 323–325, 1997. View at Publisher · View at Google Scholar · View at Scopus
  63. S. N. Jin, J. F. Wen, T. T. Wang, D. G. Kang, H. S. Lee, and K. W. Cho, “Vasodilatory effects of ethanol extract of Radix Paeoniae Rubra and its mechanism of action in the rat aorta,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 188–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. Y.-Q. Zheng, W. Wei, L. Zhu, and J.-X. Liu, “Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats,” Inflammation Research, vol. 56, no. 5, pp. 182–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. C. S. Seo, J.-A. Lee, D. Jung et al., “Simultaneous determination of liquiritin, hesperidin, and glycyrrhizin by HPLC-photodiode array detection and the anti-inflammatory effect of Pyungwi-san,” Archives of Pharmacal Research, vol. 34, no. 2, pp. 203–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Hibasami, H. Iwase, K. Yoshioka, and H. Takahashi, “Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells,” International Journal of Molecular Medicine, vol. 16, no. 2, pp. 233–236, 2005. View at Google Scholar · View at Scopus
  67. Z.-A. Chen, J.-L. Wang, R.-T. Liu et al., “Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells,” Cytotechnology, vol. 60, no. 1–3, pp. 125–132, 2009. View at Publisher · View at Google Scholar · View at Scopus